Windlas Biotech Limited

Web: windlasbiotech.com NSE: WINDLAS BSE: 543329 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

888 19(-2%)

Volume

65k as on 23, Jun

Open

1,020

High

1,032

Low

1,006

906

VWAP

862

52 Week High

1,182

52 Week Low

697

Viand Research Rating

Quality Score

36/100

Growth Score

42/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,831

No. of Shares

2.06

P/E

35.6

P/B

4.84

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

13.59

ROCE

Profit Growth

Listing Date

16-Aug-21

Rank/Sector Rank

#1193/#103

Promoter Holding

63.31%

FII Holding

2.04%

DII Holding

9.84%

Price Chart

Price Performance

1 Week3%

1 Month8%

3 Months17%

6 Months13%

1 Year13%

YTD13%

Moving Average

5 Day SMA831

10 Day SMA826

20 Day SMA822

30 Day SMA807

50 Day SMA826

61 Day SMA816

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	920	870	890	927
Resistance 2	890	866	873	894
Resistance 1	874	862	862	881
Pivot Point	844	857	844	848
Support 1	828	853	827	835
Support 2	798	849	816	802
Support 3	782	845	798	789

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Jun 2026	May 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 63.31%	(1.41) 63.31%	(-0.11) 61.90%	(0.01) 61.98%	(-0.41) 61.98%	(0.01) 62.34%	(-0.21) 62.34%	(0.01) 62.51%	(0.01) 62.51%	(-0.31) 62.51%	(0.01) 62.82%	(0.01) 62.82%	(0.01) 62.82%	(0.51) 62.82%	(1.61) 62.37%	(0.81) 60.75%	(0.01) 59.95%	(0.01) 59.95%	(0.01) 59.95%	(0.01) 59.95%	(0.01) 59.95%
FIIs	(1.11) 2.04%	(0.41) 0.99%	(-0.31) 0.60%	(-0.21) 0.93%	(-0.31) 1.11%	(-0.11) 1.44%	(0.01) 1.52%	(-0.51) 1.55%	(0.41) 2.00%	(0.41) 1.59%	(-0.21) 1.18%	(0.61) 1.35%	(0.01) 0.80%	(-0.51) 0.80%	(-0.11) 1.32%	(-0.71) 1.45%	(-1.01) 2.19%	(-0.21) 3.21%	(-0.41) 3.40%	(-2.51) 3.77%	(0.01) 6.24%
DIIs	(-0.41) 9.84%	(-1.61) 10.20%	(0.41) 11.80%	(0.01) 11.44%	(0.21) 11.44%	(0.31) 11.22%	(0.61) 10.89%	(0.71) 10.26%	(-0.81) 9.58%	(-1.51) 10.35%	(0.11) 11.82%	(0.21) 11.71%	(0.01) 11.52%	(-0.11) 11.53%	(-0.61) 11.61%	(1.11) 12.20%	(-1.11) 11.14%	(2.41) 12.23%	(-1.51) 9.83%	(0.61) 11.30%	(0.01) 10.75%
Public	24.80%	25.49%	25.69%	25.64%	25.48%	25.01%	25.25%	25.67%	25.91%	25.55%	24.19%	24.11%	24.85%	24.84%	24.68%	25.59%	26.71%	24.62%	26.82%	24.99%	23.06%
No. of Shareholders	44,996	46,084	44,769	45,461	45,433	45,887	46,383	46,590	45,706	45,824	51,277	61,900	68,798	75,470	79,233	82,690	86,801	88,746	92,115	99,271	108,818

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	248	238	233	222	210	203	195	187	175	171	162	153	145	141	120	133	120	122	118	115	111
Sales Growth % (YoY)	18.1%	17.7%	19.5%	18.9%	20%	18.3%	20.2%	22.5%	21%	21.7%	35.5%	15%	20.7%	15.2%	1.8%	15.2%	8.1%	14.3%	0.3%	13.8%	8.5%
Sales Growth % (QoQ)	4.2%	2.1%	5%	5.7%	3.4%	4.1%	4.3%	6.9%	2.3%	5.6%	5.9%	5.5%	2.8%	17.5%	-9.8%	10.8%	-1.6%	3.4%	2.6%	3.6%	-
Expenses	221	213	209	194	184	177	170	164	154	149	142	134	128	124	106	117	106	108	105	102	99
Operating Profit	27	25	24	29	27	26	25	23	21	22	20	19	17	16	14	16	14	14	13	13	12
OPM %	11	11	10	13	13	13	13	12	12	13	13	12	12	12	12	12	12	11	11	11	11
Other Income	5	4	5	4	5	5	4	5	4	4	3	3	3	2	2	3	3	3	2	1	1
Interest	2	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	7	8	8	8	7	8	7	6	6	4	3	3	3	4	3	3	3	3	3	3	3
Profit before tax	23	20	20	24	23	21	20	20	18	23	20	18	16	15	13	16	14	14	11	11	10
Tax %	23	21	25	25	24	22	24	23	26	25	24	23	26	24	28	22	28	-8	28	24	30
Net Profit	18	16	15	18	18	16	15	16	13	17	15	14	12	11	9	12	10	15	8	8	7
Net Profit Growth % (QoQ)	12.5%	6.7%	-16.7%	-	12.5%	6.7%	-6.2%	23.1%	-23.5%	13.3%	7.1%	16.7%	9.1%	22.2%	-25%	20%	-33.3%	87.5%	-	14.3%	-
Net Profit Growth % (YoY)	-	-	-	12.5%	38.5%	-5.9%	-	14.3%	8.3%	54.5%	66.7%	16.7%	20%	-26.7%	12.5%	50%	42.9%	-	-	-	-
TTM Net Profit	67	67	67	67	65	60	61	61	59	58	52	46	44	42	46	45	41	38	23	15	0
EPS in Rs	8.55	7.59	7.09	8.45	8.43	7.77	7.29	7.49	6.45	8.15	7.26	6.75	5.8	5.38	4.26	5.59	4.5	6.79	3.81	3.81	3.67

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
Sales	904	760	631	513	466	428	329	288	320	315	274
Sales Growth %	19%	20.4%	23%	10.1%	9%	30%	14.1%	-10%	1.6%	15.2%	-
Expenses	799	666	553	453	413	373	288	244	284	290	253
Operating Profit	105	94	78	60	53	55	41	44	36	25	20
OPM %	12	12	12	12	11	13	12	15	11	8	7
Other Income	18	18	13	10	7	-29	1	2	5	4	1
Interest	5	4	1	1	1	1	2	4	5	5	7
Depreciation	31	28	13	12	12	13	9	8	11	9	9
Profit before tax	87	79	77	57	46	11	31	35	25	14	6
Tax %	24	24	25	25	16	55	27	36	33	35	20
Net Profit	66	61	58	43	39	5	22	22	17	9	5
Net Profit Growth %	8.2%	5.2%	34.9%	10.3%	680%	-77.3%	-	29.4%	88.9%	80%	-
EPS in Rs	31.48	28.94	27.95	20.05	17.69	7.81	35.03	35.05	30.24	16.41	8.14
Dividend Payout %	20	20	20	20	20	0	0	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
Cash from Operating Activity	105	68	109	61	9	11	21	22	39	7	47
Cash from Investing Activity	-92	-74	-92	-14	-154	-20	-9	-7	-11	-39	-62
Cash from Financing Activity	-13	1	-15	-44	130	1	-6	-8	-25	5	38
Net Cash Flow	0	-5	2	3	-15	-8	5	7	4	-27	24

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
Equity Capital	11	11	10	10	10	10	11	6	6	6	6	6	6
Reserves	570	524	495	461	440	392	384	193	210	188	158	141	132
Borrowings	35	31	33	19	4	5	7	32	27	30	43	62	53
Other Liabilities	291	249	222	257	172	121	89	65	100	73	93	94	90
Total Liabilities	907	814	760	747	626	529	491	296	344	297	299	304	281
Fixed Assets	213	217	223	188	179	109	91	96	68	62	58	56	56
CWIP	60	24	5	31	6	15	8	0	0	5	11	15	9
Investments	268	246	223	182	173	107	65	23	121	121	123	121	95
Other Assets	366	327	308	346	268	298	327	177	154	110	107	111	121
Total Assets	907	814	760	747	626	529	491	296	344	297	299	304	281

Delivery

Delivery Data: WINDLAS

#	Date	866 36% 1182	Value (Cr)	Q/T 15	Del 38	Del 16
1	21-Oct	881	7	10	53	4
2	19-Oct	906	9	7	51	5
3	16-Oct	917	8	10	53	4
4	15-Oct	924	6	9	51	3
5	14-Oct	917	5	10	45	2
6	13-Oct	935	8	9	35	3
7	12-Oct	949	4	9	54	2
8	9-Oct	949	12	12	43	5
9	8-Oct	992	12	14	52	6
10	7-Oct	1022	8	11	59	5
11	6-Oct	1036	7	9	47	3
12	5-Oct	1018	11	9	44	5
13	1-Oct	1082	7	9	50	3
14	30-Sep	1091	6	11	48	3
15	29-Sep	1096	12	8	45	5
16	28-Sep	1103	13	12	38	5
17	25-Sep	1103	5	10	43	2
18	24-Sep	1094	6	11	56	3
19	23-Sep	1077	10	10	56	6
20	22-Sep	1102	6	10	52	3
21	21-Sep	1129	15	9	47	7
22	18-Sep	1109	8	11	53	4
23	17-Sep	1118	13	10	47	6
24	16-Sep	1075	12	10	56	7
25	15-Sep	1098	9	8	52	5
26	11-Sep	1129	8	9	55	4
27	10-Sep	1129	7	10	53	3
28	9-Sep	1142	17	13	40	7
29	8-Sep	1146	13	11	43	6
30	7-Sep	1155	32	13	36	11
31	4-Sep	1126	22	14	44	9
32	3-Sep	1127	47	21	37	17
33	2-Sep	1097	169	23	18	30
34	1-Sep	1008	5	11	53	2
35	31-Aug	994	8	12	50	4
36	28-Aug	999	3	12	56	2
37	27-Aug	987	3	11	48	1
38	26-Aug	978	6	16	52	3
39	25-Aug	991	8	12	50	4
40	24-Aug	992	15	16	49	8
41	21-Aug	994	17	12	40	7
42	20-Aug	988	14	13	37	5
43	19-Aug	965	42	19	34	14
44	18-Aug	918	3	11	51	2
45	17-Aug	933	6	12	50	3
46	14-Aug	949	14	20	57	8
47	13-Aug	950	26	19	32	8
48	12-Aug	895	14	17	38	6

Daily Market Cap

Date	Total Market Cap	Change	Chg %
21-Oct	1,832c	10c	0.53
19-Oct	1,841c	42c	2.24
17-Oct	1,883c	0	0
16-Oct	1,883c	22c	1.13
15-Oct	1,905c	5c	0.26
14-Oct	1,910c	12c	0.62
13-Oct	1,922c	30c	1.51
12-Oct	1,951c	8c	0.40
09-Oct	1,959c	103c	4.99
08-Oct	2,062c	135c	6.16
05-Oct	2,197c	64c	2.83
01-Oct	2,261c	41c	1.78
29-Sep	2,302c	32c	1.42
28-Sep	2,270c	37c	1.64
25-Sep	2,233c	18c	0.82
24-Sep	2,252c	30c	1.31
22-Sep	2,282c	6c	0.27
17-Sep	2,288c	73c	3.10
10-Sep	2,361c	58c	2.39
07-Sep	2,419c	75c	3.21
04-Sep	2,344c	0	0

Stock Checklist

Price is above from 52 week high low average: 39%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 8 fund scheme(s) across 3 fund house(s) as of Oct26 · Total value ₹172 Cr · 2 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
ICICI Prudential Mutual Fund	2	0.57%	-	77.7
Bandhan Mutual Fund	4	0.08%	-	53.5
UTI Mutual Fund	2	1.42%	+0.14%	40.6

Windlas Biotech Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements